United Therapeutics (UTHR) Misses Q1 EPS by 19c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $542.66 -0.13%
EPS Growth %: +12.6%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
CGEH, NAKA, APOG, More
EPS Growth %: +12.6%
Financial Fact:
Total revenues: 408.2M
Today's EPS Names:
CGEH, NAKA, APOG, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q1 EPS of $3.02, $0.19 worse than the analyst estimate of $3.21. Revenue for the quarter came in at $369 million versus the consensus estimate of $397.42 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
- Trip.com Group (TCOM) Misses Q1 EPS by 41c
- Benchmark Reiterates Buy Rating on Kura Sushi USA Inc. (KRUS) Ahead of Q3 Print
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
